Christopher & Banks Corp. (CBK) Posts Better than Expected Q2 Loss of 19c/Share; Comps Up 5.5%
Tweet
Share
E-mailGet Alerts CBK Hot Sheet
Price: $35.43 --0%
Financial Fact:
Net income (loss) (in dollars per share): 0.09
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Net income (loss) (in dollars per share): 0.09
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Christopher & Banks Corp. (NYSE: CBK) reported Q2 EPS of ($0.19), $0.05 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $103.4 million versus the consensus estimate of $102.52 million.
Same store sales increased 5.5% in the second quarter of fiscal 2012, as compared to the comparable period last year.
For earnings history and earnings-related data on Christopher & Banks Corp. (CBK) click here.
Same store sales increased 5.5% in the second quarter of fiscal 2012, as compared to the comparable period last year.
For earnings history and earnings-related data on Christopher & Banks Corp. (CBK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Prosensa Holding N.V. (RNA) Reports Q2 Loss of $1.18
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
Earnings, Retail SalesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
